title: ERCC1 as Predictor of Platinum Benefit in Non-Small-Cell Lung Cancer.
authors.affiliation: Sophie Postel-Vinay and Jean-Charles Soria, Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Paris-Saclay University, and INSERM, UMR981, Villejuif, France.
authors.forename: Sophie
authors.initials: S
authors.lastname: Postel-Vinay
authors.affiliation: Sophie Postel-Vinay and Jean-Charles Soria, Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Paris-Saclay University, and INSERM, UMR981, Villejuif, France.
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Soria
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D015415:Biomarkers; D002289:Carcinoma, Non-Small-Cell Lung; D004268:DNA-Binding Proteins; D004720:Endonucleases; D006801:Humans; D008175:Lung Neoplasms; D010984:Platinum; D011446:Prospective Studies
chemical_list: D015415:Biomarkers; D004268:DNA-Binding Proteins; D010984:Platinum; C071447:ERCC1 protein, human; D004720:Endonucleases